Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome. (2nd September 2020) - Steinhardt, MJ; Wiebecke, S; Weismann, D; Frantz, S; Tony, HP; Klinker, H; Schmalzing, M